Antibiotic Resistance Market by Type, Mechanism of Action, Spectrum of Activity, Drug Class, Route of Administration, End User, Distribution Channel - Global Forecast 2025-2030- Product Image

Sale

Antibiotic Resistance Market by Type, Mechanism of Action, Spectrum of Activity, Drug Class, Route of Administration, End User, Distribution Channel - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 6014952

UP TO €663EUR$697USD£559GBP OFF until Dec 31^st 2024

The Antibiotic Resistance Market grew from USD 9.02 billion in 2023 to USD 9.87 billion in 2024. It is expected to continue growing at a CAGR of 9.40%, reaching USD 16.93 billion by 2030.

Antibiotic resistance, a pressing global health concern, arises when bacteria evolve to withstand the drugs designed to kill them, rendering treatments ineffective and leading to more severe illnesses. This phenomenon necessitates a robust market scope because it underscores the urgent need for new antibiotics, alternative therapies, and diagnostic tools. The application of market research within this context involves assessing the development and deployment of novel antibiotics, rapid diagnostic technologies, and infection prevention measures. Key end-users include hospitals, outpatient clinics, pharmaceutical companies, and research institutions focused on combating resistant strains. Influencing growth factors encompass the increasing incidence of antibiotic-resistant infections, heightened public awareness, and rising healthcare expenditures. Additionally, government initiatives funding research and development, along with policies promoting antibiotic stewardship, significantly propel market expansion. However, the market faces limitations, such as high costs and lengthy timelines associated with drug development, regulatory hurdles, and a diminishing pipeline of new antibiotics due to economic disincentives. Moreover, there are challenging factors like the lack of rapid diagnostics and variable resistance patterns, which complicate treatment protocols. Despite these obstacles, there are potential opportunities in the surge of personalized medicine, which tailors treatments based on genetic profiling, and the use of bacteriophages and biotherapeutics as alternatives to traditional antibiotics. Business growth could also be nurtured by investing in research that explores the microbiome's role in resistance, innovating rapid diagnostic platforms, and enhancing global collaboration for data sharing. The nature of this market is highly dynamic and research-intensive, requiring continual adaptation and innovation to stay ahead of evolving bacterial threats. Hence, strategic investments into cutting-edge research and technology, alongside fostering partnerships across sectors, are pivotal to tackling antibiotic resistance effectively.

Understanding Market Dynamics in the Antibiotic Resistance Market

The Antibiotic Resistance Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- High healthcare costs associated with antibiotic-resistant infections contributing to market growth
- Growing adoption of rapid diagnostic tests for antibiotic resistance driving market demand
- Increased collaboration between pharmaceutical companies and research institutions to address antibiotic resistance
- Emerging markets showing significant interest and potential in antibiotic resistance solutions
Market Restraints
- Regulatory hurdles and approval delays hindering the introduction of novel antibiotics
Market Opportunities
- Development of novel antibiotics targeting antibiotic resistant bacterial strains to address critical healthcare needs
- Implementation of advanced diagnostic tools for early detection and management of antibiotic resistant infections
- Exploration of alternative therapies such as bacteriophages and probiotics to combat antibiotic resistance
Market Challenges
- Lack of collaboration between pharmaceutical companies and academic institutions in antibiotic research

Exploring Porter’s Five Forces for the Antibiotic Resistance Market

Porter’s Five Forces framework further strengthens the insights of the Antibiotic Resistance Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Antibiotic Resistance Market

External macro-environmental factors deeply influence the performance of the Antibiotic Resistance Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Antibiotic Resistance Market

The Antibiotic Resistance Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antibiotic Resistance Market

The Antibiotic Resistance Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Antibiotic Resistance Market

The Antibiotic Resistance Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antibiotic Resistance Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allergan plc, Amgen Inc., AstraZeneca PLC, Aurobindo Pharma Limited, Bayer AG, Bristol-Myers Squibb Company, Cipla Limited, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antibiotic Resistance Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Antibacterial Products
- Antifungal Products
- Antiparasitic Products
- Antiviral Products
Mechanism of Action
- Cell Wall Synthesis Inhibitors
- DNA Gyrase Inhibitors
- Protein Synthesis Inhibitors
- RNA Polymerase Inhibitors
Spectrum of Activity
- Broad-Spectrum Antibiotics
- Narrow-Spectrum Antibiotics
Drug Class
- Cephalosporins
- Fluoroquinolones
- Macrolides
- Penicillins
- Tetracyclines
Route of Administration
- Intravenous
- Oral
End User
- Clinics
- Homecare Settings
- Hospitals
Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High healthcare costs associated with antibiotic-resistant infections contributing to market growth
5.1.1.2. Growing adoption of rapid diagnostic tests for antibiotic resistance driving market demand
5.1.1.3. Increased collaboration between pharmaceutical companies and research institutions to address antibiotic resistance
5.1.1.4. Emerging markets showing significant interest and potential in antibiotic resistance solutions
5.1.2. Restraints
5.1.2.1. Regulatory hurdles and approval delays hindering the introduction of novel antibiotics
5.1.3. Opportunities
5.1.3.1. Development of novel antibiotics targeting antibiotic resistant bacterial strains to address critical healthcare needs
5.1.3.2. Implementation of advanced diagnostic tools for early detection and management of antibiotic resistant infections
5.1.3.3. Exploration of alternative therapies such as bacteriophages and probiotics to combat antibiotic resistance
5.1.4. Challenges
5.1.4.1. Lack of collaboration between pharmaceutical companies and academic institutions in antibiotic research
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Antibiotic Resistance Market, by Type

6.1. Introduction
6.2. Antibacterial Products
6.3. Antifungal Products
6.4. Antiparasitic Products
6.5. Antiviral Products

7. Antibiotic Resistance Market, by Mechanism of Action

7.1. Introduction
7.2. Cell Wall Synthesis Inhibitors
7.3. DNA Gyrase Inhibitors
7.4. Protein Synthesis Inhibitors
7.5. RNA Polymerase Inhibitors

8. Antibiotic Resistance Market, by Spectrum of Activity

8.1. Introduction
8.2. Broad-Spectrum Antibiotics
8.3. Narrow-Spectrum Antibiotics

9. Antibiotic Resistance Market, by Drug Class

9.1. Introduction
9.2. Cephalosporins
9.3. Fluoroquinolones
9.4. Macrolides
9.5. Penicillins
9.6. Tetracyclines

10. Antibiotic Resistance Market, by Route of Administration

10.1. Introduction
10.2. Intravenous
10.3. Oral

11. Antibiotic Resistance Market, by End User

11.1. Introduction
11.2. Clinics
11.3. Homecare Settings
11.4. Hospitals

12. Antibiotic Resistance Market, by Distribution Channel

12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies

13. Americas Antibiotic Resistance Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Antibiotic Resistance Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Antibiotic Resistance Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape

16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. ANTIBIOTIC RESISTANCE MARKET RESEARCH PROCESS
FIGURE 2. ANTIBIOTIC RESISTANCE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 19. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. ANTIBIOTIC RESISTANCE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. ANTIBIOTIC RESISTANCE MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ANTIBIOTIC RESISTANCE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANTIBIOTIC RESISTANCE MARKET DYNAMICS
TABLE 7. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ANTIBACTERIAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ANTIFUNGAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ANTIPARASITIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ANTIVIRAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DNA GYRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY RNA POLYMERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIBIOTIC RESISTANCE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 61. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 62. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CANADA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 69. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 98. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 99. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 100. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. CHINA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 105. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 106. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. INDIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 119. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 120. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. JAPAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 161. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 162. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 163. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. THAILAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 183. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 184. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 185. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. DENMARK ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 190. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 191. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 197. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 198. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FINLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 204. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 205. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 206. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. FRANCE ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 211. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 212. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 213. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. GERMANY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 225. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 226. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 227. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ITALY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 246. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 247. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 253. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 254. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 255. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. POLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 260. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 261. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 262. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. QATAR ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 288. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 289. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 290. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 291. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. SPAIN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 309. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 310. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 312. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. TURKEY ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY SPECTRUM OF ACTIVITY, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM ANTIBIOTIC RESISTANCE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. ANTIBIOTIC RESISTANCE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 329. ANTIBIOTIC RESISTANCE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Antibiotic Resistance Market, which are profiled in this report, include:

AbbVie Inc.
Allergan plc
Amgen Inc.
AstraZeneca PLC
Aurobindo Pharma Limited
Bayer AG
Bristol-Myers Squibb Company
Cipla Limited
Eli Lilly and Company
Gilead Sciences, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Roche Holding AG
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 9.87 Billion
Forecasted Market Value ( USD ) by 2030	$ 16.93 Billion
Compound Annual Growth Rate	9.4%
Regions Covered	Global
No. of Companies Mentioned	21

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3373EUR$3,545USD£2,845GBP €3748EUR$3,939USD£3,161GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€5968EUR$6,272USD£5,033GBP €6631EUR$6,969USD£5,592GBP

Understanding Market Dynamics in the Antibiotic Resistance Market

Exploring Porter’s Five Forces for the Antibiotic Resistance Market

Applying PESTLE Analysis to the Antibiotic Resistance Market

Analyzing Market Share in the Antibiotic Resistance Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antibiotic Resistance Market

Strategic Recommendations for Success in the Antibiotic Resistance Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030

Antibiotic Resistance Market Size, Share & Trends Analysis Report by Disease (cUTI, CDI), Pathogen, Drug Class, Mechanism of Action, Distribution Channel, Region, and Segment Forecasts, 2024-2030

Antibiotic Resistance - Market Insights, Competitive Landscape, and Market Forecast - 2030

Peptide Antibiotics Market by Type, Disease, Route of Administration, Distribution Channel - Global Forecast 2025-2030

Balofloxacin Market by Category, Distribution Channel, Application, End-User - Global Forecast 2025-2030